H-1-magnetic resonance spectroscopy in amyotrophic lateral sclerosis

Citation
Wg. Bradley et al., H-1-magnetic resonance spectroscopy in amyotrophic lateral sclerosis, J NEUR SCI, 169(1-2), 1999, pp. 84-86
Citations number
16
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF THE NEUROLOGICAL SCIENCES
ISSN journal
0022510X → ACNP
Volume
169
Issue
1-2
Year of publication
1999
Pages
84 - 86
Database
ISI
SICI code
0022-510X(19991031)169:1-2<84:HRSIAL>2.0.ZU;2-F
Abstract
H-1-magnetic resonance spectroscopy (MRS) is potentially a powerful tool fo r the investigation of the chemicals of the brain in vivo in health and dis ease. Levels of N-acetyl-aspartate (NAA) in the motor cortex and brainstem of patients with amyotrophic lateral sclerosis (ALS) have been reported to be reduced by up to 68% and in one report the level of glutamate in the bra instem was increased by 58%. We studied levels of metabolites in the cerebr al cortex and brainstem of 20 ALS patients and 14 age-matched controls with a 1.5 Tesla Picker magnet using MRS. We used the same spectra for determin ing both the area of the metabolite peaks expressed as a ratio of the area of the creatine (Cr) peak, and the absolute concentrations using the Proven cher LC model. These produced different results. With the LC model, the NAA content of the motor cortex of ALS patients was reduced by 7.7% (P=0.015), and that of the brainstem was reduced by 21.5% (P=0.035), compared with co ntrols. The degree of reduction of NAA was related to the severity of upper motor neuron abnormalities. No effect of treatment with anti-glutamate age nts on NAA concentration could be detected. Concentrations of other metabol ites were not affected in ALS. It appears that MRS is a technique that is s till in development, and that further refinement is required before it can be used to understand disease mechanisms and investigate treatment in ALS. (C) 1999 Elsevier Science B.V. All rights reserved.